Conba Group Overview

  • Year Founded
  • 1969

Year Founded

  • Status
  • Public

  • Employees
  • 7,826

Employees

  • Stock Symbol
  • 600572

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $0.62
  • (As of Wednesday Closing)

Conba Group General Information

Description

Zhejiang Conba Pharmaceutical Co Ltd is engaged in the Pharmaceutical research and development, manufacturing, wholesale and distribution business.

Contact Information

Formerly Known As
Lanxi Yunshan Pharmaceutical Factory
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 568 Binkang Road, Binjiang Science and Technology Economic Park
  • Hangzhou High-tech Development Zone
  • Hangzhou, Zhejiang 310052
  • China
+86 0571
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHG
Corporate Office
  • Number 568 Binkang Road, Binjiang Science and Technology Economic Park
  • Hangzhou High-tech Development Zone
  • Hangzhou, Zhejiang 310052
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conba Group Stock Performance

As of 18-Nov-2026, Conba Group’s stock price is $0.62. Its current market cap is $1.58B with 2.54B shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.62 $0.63 $0.55 - $0.76 $1.58B 2.54B 46.9M $0.03

Conba Group Financials Summary

As of 30-Sep-2026, Conba Group has a trailing 12-month revenue of $991M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,532,371 1,567,848 1,610,157 1,649,939
Revenue 990,590 900,173 907,979 951,648
EBITDA 91,643 136,308 154,685 152,007
Net Income 66,265 65,963 86,742 83,616
Total Assets 1,561,521 1,426,995 1,356,389 1,585,396
Total Debt 28,279 43,407 58,049 146,163
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Conba Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Conba Group‘s full profile, request access.

Request a free trial

Conba Group Patents

Conba Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023246355-A1 Ginkgo leaf organic acid extract, method for prearing same and use thereof Inactive 21-Jun-2022
GB-202112782-D0 Compound separated from root bark of ginkgo biloba and use thereof Active 29-Mar-2019
GB-2597145-A Compound separated from root bark of ginkgo biloba and use thereof Active 29-Mar-2019
GB-2597145-B Compound separated from root bark of ginkgo biloba and use thereof Active 29-Mar-2019
WO-2020199568-A1 Compound separated from root bark of ginkgo biloba and use thereof Inactive 29-Mar-2019 C07D307/91
To view Conba Group’s complete patent history, request access »

Conba Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Conba Group Investments & Acquisitions (15)

Conba Group’s most recent deal was a Later Stage VC with ZhenShiMing. The deal was made on 17-Apr-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ZhenShiMing 17-Apr-2024 Later Stage VC Pharmaceuticals
Zhejiang Zhencheng Pharmaceutical Technology 23-Mar-2023 Secondary Transaction - Private Specialty Retail
Zhejiang University of Chinese Medicine Pieces 14-Oct-2022 Merger/Acquisition Pharmaceuticals
Fengdeng Enviroment 01-Dec-2021 Later Stage VC Environmental Services (B2B)
Xique Pharmaceutical 14-Apr-2020 Later Stage VC Drug Discovery
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Conba Group ESG

Risk Overview

Risk Rating

Updated January, 31, 2024

32.4 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Pharmaceuticals

Subindustry

of 438

Rank

Percentile

To view Conba Group’s complete esg history, request access »

Conba Group Exits (4)

Conba Group’s most recent exit was on 23-Mar-2023 from Zhejiang Zhencheng Pharmaceutical Technology. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Zhejiang Zhencheng Pharmaceutical Technology 23-Mar-2023 Completed
Xique Pharmaceutical 14-Apr-2020 Completed
  • 6 buyers
Zhejiang Zhencheng Pharmaceutical Technology 08-Jun-2015 Completed
Forest Packaging 27-Nov-2013 Merger/Acquisition Completed
To view Conba Group’s complete exits history, request access »

Conba Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Zhejiang University of Chinese Medicine Pieces Hangzhou, China 1989

Conba Group FAQs

  • When was Conba Group founded?

    Conba Group was founded in 1969.

  • Where is Conba Group headquartered?

    Conba Group is headquartered in Hangzhou, China.

  • What is the size of Conba Group?

    Conba Group has 7,826 total employees.

  • What industry is Conba Group in?

    Conba Group’s primary industry is Pharmaceuticals.

  • Is Conba Group a private or public company?

    Conba Group is a Public company.

  • What is Conba Group’s stock symbol?

    The ticker symbol for Conba Group is 600572.

  • What is the current stock price of Conba Group?

    As of 18-Nov-2026 the stock price of Conba Group is $0.62.

  • What is the current market cap of Conba Group?

    The current market capitalization of Conba Group is $1.58B.

  • What is Conba Group’s current revenue?

    The trailing twelve month revenue for Conba Group is $991M.

  • What is Conba Group’s annual earnings per share (EPS)?

    Conba Group’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process